Drugs / Exo-HUVEC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07144241 Comparator | Sep → Dec 2025 overdue | type 2 diabetes mellitus | Indonesia University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exo-HUVEC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07144241 ↗ |
| Modality | Other / unclassified | “exosome combination” NCT07144241 ↗ |
| Route | Intravenous | “via intravenous bolus injection” NCT07144241 ↗ |